HPGC Renmintongtai Pharmaceutical Corp Asset Resilience Ratio
HPGC Renmintongtai Pharmaceutical Corp asset resilience ratio. HPGC Renmintongtai Pharmaceutical Corp (600829) has an Asset Resilience Ratio of 0.00% as of September 2010. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See HPGC Renmintongtai Pharmaceutical Corp (600829) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of HPGC Renmintongtai Pharmaceutical Corp (1995–2009)
Asset resilience ratio of HPGC Renmintongtai Pharmaceutical Corp from 1995 to 2009. This chart shows how HPGC Renmintongtai Pharmaceutical Corp's Asset Resilience Ratio has changed over time. Read HPGC Renmintongtai Pharmaceutical Corp (600829) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down HPGC Renmintongtai Pharmaceutical Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see HPGC Renmintongtai Pharmaceutical Corp (600829) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥8.20K | 0.0% |
| Total Liquid Assets | CN¥8.20K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: HPGC Renmintongtai Pharmaceutical Corp maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
HPGC Renmintongtai Pharmaceutical Corp Industry Peers by Asset Resilience Ratio
Compare HPGC Renmintongtai Pharmaceutical Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Ajanta Pharma Limited
NSE:AJANTPHARM |
Drug Manufacturers - Specialty & Generic | 14.99% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Porton Fine Chemicals Ltd
SHE:300363 |
Drug Manufacturers - Specialty & Generic | 6.85% |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
Drug Manufacturers - Specialty & Generic | 1.26% |
HPGC Renmintongtai Pharmaceutical Corp Asset Resilience Ratio by Year (1995–2009)
HPGC Renmintongtai Pharmaceutical Corp asset resilience ratio by year from 1995 to 2009. The table below shows the annual Asset Resilience Ratio data for HPGC Renmintongtai Pharmaceutical Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2009-12-31 | 0.00% | CN¥65.16K ≈ $9.53K |
CN¥2.85 Billion ≈ $417.56 Million |
0.00pp |
| 2008-12-31 | 0.00% | CN¥87.24K ≈ $12.77K |
CN¥2.91 Billion ≈ $426.49 Million |
-0.22pp |
| 2007-12-31 | 0.22% | CN¥5.85 Million ≈ $856.25K |
CN¥2.68 Billion ≈ $392.22 Million |
+0.13pp |
| 2006-12-31 | 0.09% | CN¥2.00 Million ≈ $292.85K |
CN¥2.24 Billion ≈ $327.69 Million |
+0.08pp |
| 2003-12-31 | 0.00% | CN¥53.00K ≈ $7.76K |
CN¥1.08 Billion ≈ $157.58 Million |
+0.00pp |
| 2002-12-31 | 0.00% | CN¥1.00K ≈ $146.33 |
CN¥929.89 Million ≈ $136.07 Million |
-2.00pp |
| 2000-12-31 | 2.00% | CN¥20.00 Million ≈ $2.93 Million |
CN¥1.00 Billion ≈ $146.49 Million |
-1.67pp |
| 1999-12-31 | 3.66% | CN¥26.00 Million ≈ $3.80 Million |
CN¥709.69 Million ≈ $103.85 Million |
-0.05pp |
| 1998-12-31 | 3.72% | CN¥25.00 Million ≈ $3.66 Million |
CN¥672.44 Million ≈ $98.40 Million |
+0.69pp |
| 1997-12-31 | 3.03% | CN¥20.23 Million ≈ $2.96 Million |
CN¥667.48 Million ≈ $97.67 Million |
-0.17pp |
| 1996-12-31 | 3.20% | CN¥20.69 Million ≈ $3.03 Million |
CN¥646.29 Million ≈ $94.57 Million |
-0.98pp |
| 1995-12-31 | 4.18% | CN¥26.50 Million ≈ $3.88 Million |
CN¥634.21 Million ≈ $92.81 Million |
-- |
About HPGC Renmintongtai Pharmaceutical Corp
HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese and Western patent medicines, Chinese herbal medicines and slices, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosm… Read more